| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senior VP, Chief Pharma Dev.
1 company
Waltermire Robert E. is a Senior VP, Chief Pharma Dev. at MADRIGAL PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $7.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sale+OE | 14,113 | $341.32 | $4,817,103.60 | -12.2% | -18.1% | +26.6% | |
| Feb 28, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sell | 1,227 | $341.07 | $418,488.05 | -13.9% | -20.9% | +26.7% | |
| Jan 24, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sell | 103 | $335.24 | $34,529.72 | -2.0% | -2.5% | +46.4% | |
| Jan 17, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sell | 442 | $273.41 | $120,847.22 | -8.0% | +2.7% | +70.8% | |
| Jun 14, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sale+OE | 1,900 | $280.00 | $532,000.00 | -25.7% | -15.4% | +6.5% | |
| Jun 12, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sale+OE | 2,000 | $285.00 | $570,000.00 | -26.7% | -17.5% | +4.0% | |
| May 21, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sell | 1,036 | $231.34 | $239,668.24 | -15.9% | +5.9% | +14.3% | |
| Dec 15, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sale+OE | 4,000 | $235.50 | $942,000.00 | -14.0% | +2.7% | +28.4% | |
| Dec 13, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sale+OE | 3,800 | $222.82 | $846,700.00 | -13.4% | +15.5% | +33.1% | |
| Mar 1, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Senior VP, Chief Pharma Dev. | Sale+OE | 10,000 | $273.24 | $2,732,438.36 | -19.0% | +0.3% | -15.4% |